Article
Benzylic Dehydroxylation of Echinocandin Antifungal Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase.
Journal of the American Chemical Society - 6 Apr 2022
Logviniuk Dana, Jaber Qais Z, Dobrovetsky Roman, Kozer Noga, Ksiezopolska Ewa, Gabaldón Toni, Carmeli Shmuel, Fridman Micha
Abstract excerpt
Each year, infections caused by fungal pathogens claim the lives of about 1.6 million people and affect the health of over a billion people worldwide. Among the most recently developed antifungal drugs are the echinocandins, which noncompetitively inhibit β-glucan synthase, a membrane-bound protein complex that catalyzes the formation of the main polysaccharide component of the fungal cell wall. Resistance to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
